Dataset Information

NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma.

ABSTRACT: Infantile hemangioma is a vascular tumor characterized by the rapid growth of disorganized blood vessels followed by slow spontaneous involution. The underlying molecular mechanisms that regulate hemangioma proliferation and involution still are not well elucidated. Our previous studies reported that NOGOB receptor (NGBR), a transmembrane protein, is required for the translocation of prenylated RAS from the cytosol to the plasma membrane and promotes RAS activation. Here, we show that NGBR was highly expressed in the proliferating phase of infantile hemangioma, but its expression decreased in the involuting phase, suggesting that NGBR may have been involved in regulating the growth of proliferating hemangioma. Moreover, we demonstrate that NGBR knockdown in hemangioma stem cells (HemSCs) attenuated growth factor-stimulated RAS activation and diminished the migration and proliferation of HemSCs, which is consistent with the effects of RAS knockdown in HemSCs. In vivo differentiation assay further shows that NGBR knockdown inhibited blood vessel formation and adipocyte differentiation of HemSCs in immunodeficient mice. Our data suggest that NGBR served as a RAS modulator in controlling the growth and differentiation of HemSCs.

SUBMITTER: Hu W

PROVIDER: S-EPMC7934876 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma.

Hu Wenquan W Liu Zhong Z Salato Valerie V North Paula E PE Bischoff Joyce J Kumar Suresh N SN Fang Zhi Z Rajan Sujith S Hussain M Mahmood MM Miao Qing R QR

JCI insight 20210208 3

Infantile hemangioma is a vascular tumor characterized by the rapid growth of disorganized blood vessels followed by slow spontaneous involution. The underlying molecular mechanisms that regulate hemangioma proliferation and involution still are not well elucidated. Our previous studies reported that NOGOB receptor (NGBR), a transmembrane protein, is required for the translocation of prenylated RAS from the cytosol to the plasma membrane and promotes RAS activation. Here, we show that NGBR was h ...[more]

PMID: 33400686

Similar Datasets

Project description:The enhanced migratory ability of endometrial stromal cells (ESCs) is a key factor in the formation of functional endometrium?like tissues outside the uterine cavity during endometriosis (EMS). Although accumulating evidence has suggested the importance of microRNAs (miRNAs) in the pathogenesis of EMS, the role of particular miRNAs in the invasiveness of ESCs remain poorly understood. In the present study, the function of miRNAs in the invasiveness of ESCs, along with the associated underlying mechanism involved, were investigated. Initially, the expression patterns of miRNAs in the ectopic and eutopic endometrium isolated from patients with EMS were analyzed using microarray. MicroRNA?202?5p (miR?202) was selected for further study due to its previously reported suppressive effects on the invasion in various types of cancers. The expression of miR?202 and K?Ras in eutopic and ectopic endometrioma tissues were detected using reverse transcription?quantitative PCR, immunohistochemistry and western blotting. The migration and invasion ability of ESCs was determined using wound healing and Transwell invasion assays, respectively. Compared with that from healthy individuals, miR?202 expression was demonstrated to be lower in the eutopic endometrium from patients with EMS, which was even lower in ectopic endometrium. Functional experiments in primary ESCs revealed that enhanced miR?202 expression suppressed the cell invasion and migration abilities, which was also accompanied with increased E?cadherin and reduced N?cadherin expression in ESCs, suggesting its potentially suppressive role in epithelial?mesenchymal transition. K?Ras is a well?known regulator of the ERK signaling pathway that was shown to be directly targeted and negatively regulated by miR?202. In addition, K?Ras expression was found to be upregulated in the ectopic endometrium, where it correlated negatively with that of miR?202. Knocking down K?Ras expression mimicked the anti?invasive effects of miR?202 overexpression on ESCs, whilst K?Ras overexpression attenuated the inhibitory role of miR?202 overexpression in ESC invasion. The K?Ras/Raf1/MEK/ERK signaling pathway was also blocked by miR?202 overexpression. These findings suggested that miR?202 inhibited ESC migration and invasion by inhibiting the K?Ras/Raf1/MEK/ERK signaling pathway, rendering miR?202 a candidate for being a therapeutic target for EMS.

Project description:BACKGROUND:Ras are small cellular GTPases which regulate diverse cellular processes. It has three isoforms: H-Ras, K-Ras, and N-Ras. Owing to the N-terminus (1-165 residues) sequence homology these isoforms were thought to be functionally redundant. However, only K-Ras-deficient mice but not H-Ras- and N-Ras-deficient mice show embryonic lethality. Similarly, mutations in a given Ras isoform are associated with a particular type of cancer. Moreover, we have previously reported that Ras isoforms perform unique functions in Leishmania major infection. Thus, Ras isoforms are implicated to have signaling and functional specificity but the mechanism remains to be elucidated. RESULT:Using CD40 as a model receptor, we showed that depending on the strength of signaling, specific Ras isoforms are activated. Weak CD40 signal activates N-Ras, whereas strong signal activates H-Ras and K-Ras. Additionally, we showed that suppression of N-Ras expression reduced CD40-induced extracellular signal-regulated kinase-1/2 (ERK-1/2) activation and Interleukin (IL)-10 production; whereas suppression of H-Ras or K-Ras reduced CD40-induced p38 mitogen-activated protein kinase (p38MAPK) activation and IL-12 production. Furthermore, we showed that Ras isoforms have activator (GEF) specificity as weak CD40 signal-activated N-Ras requires Sos-1/2 whereas strong CD40 signal-activated H-Ras/K-Ras requires Ras-GRP as the guanine-nucleotide exchange factor (GEF) inducing ERK-1/2- or p38MAPK-mediated IL-10 or IL-12 productions, respectively, in macrophages. Silencing of syk reduced CD40-induced N-Ras activation but silencing of lyn inhibited H-Ras and K-Ras activation. In CD40 signaling, Ras isoforms also showed effector specificity; while H-Ras and K-Ras showed specificity for phosphatidyl inositol-3 kinase activation at high dose of CD40 stimulation, N-Ras primarily associated with Raf-1 at low dose of CD40 stimulation. Moreover, fractal analysis showed that functional site surface roughness for H-Ras (SurfaceFD?=?2.39) and K-Ras (SurfaceFD?=?2.39) are similar but significantly different from N-Ras (SurfaceFD?=?2.25). CONCLUSION:The activator and effector specificities of Ras isoforms in CD40 signaling indicated their differential involvement in CD40 pathway and in maintaining the reciprocity. Our observations reveal Ras-regulated signaling outcome and its potential for developing Ras isoform-targeted immunotherapy and prophylaxis.

Dataset Information

NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma.

Publications

NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets